Clinical trials

5

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia

ORACLE is a Europe-wide study that will follow 250 people with critical limb-threatening ischemia (CLTI). It aims to see how well orbital atherectomy (OA) works in real-life practice. OA is a procedure that uses a tiny spinning tool to gently remove hard calcium from inside an artery, helping to open the vessel so other treatments-like balloons or stents-can work better. The study focuses on people who have heavily calcified arteries in the femoropopliteal or infrapopliteal areas of the leg.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cardiovascular and Interventional Radiological Society of EuropeUpdated: Jul 2, 2026
Eligibility criteria

Rutherford classification category ≥4; [+3]

Minors and other vulnerable populations who may not be able to give informed con... [+5]

Status: Not yet recruiting

Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment

BRIGHT is a Europe-wide study that will follow up to 250 adults with bleeding symptoms from haemmorhoids (Grade II-III categories). It aims to understand how well a minimally invasive procedure called haemorrhoid artery embolization (HAE) works in everyday clinical practice, which is a technique that blocks the blood vessels feeding the haemorrhoids. As this technique does not require major surgery, HAE offers several benefits such as less trauma, quicker recovery, and the use of only local anaesthesia.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cardiovascular and Interventional Radiological Society of EuropeUpdated: Jul 2, 2026
Eligibility criteria

Adult patients presenting bleeding Grade II-III haemorrhoids with French bleedin... [+1]

Minors and other vulnerable populations who may not be able to give informed con... [+10]

Status: Not yet recruiting

REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia

RESCUE is a Europe-wide study that will follow 400 people with critical limb-threatening ischemia (CLTI). It aims to see how well Esprit BTK™ Everolimus Eluting Resorbable Scaffolds work in real-life medical settings. The study focuses on people who have heavily calcified arteries in the infrapopliteal areas of the leg. These drug-eluting resorbable scaffolds release a medication that helps prevent the inner wall of the blood vessel from thickening after injury or surgery. This can reduce the chance of the artery becoming blocked again (a problem called restenosis), while also giving temporary structural support to the vessel. Over time, the scaffold naturally dissolves in the body, which may lower the long-term risks associated with permanent metal stents.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cardiovascular and Interventional Radiological Society of EuropeUpdated: Jul 2, 2026
Eligibility criteria

Rutherford classification category ≥4; [+3]

Minors and other vulnerable populations who may not be able to give informed con... [+5]

Status: Recruiting

Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

CALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemia (CLTI). The primary objective of CALCIO is to understand the effectiveness of IVL in promoting wound healing and preventing amputation. The secondary objectives of CALCIO are to evaluate the immediate effectiveness of the treatment in restoring vessel patency as well as its safety and impact on patients' quality of life.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cardiovascular and Interventional Radiological Society of EuropeUpdated: May 13, 2026Locations: 39
Eligibility criteria

Patient with chronic limb-threatening ischemia (Rutherford Category ≥4) [+2]

< 18 years old; [+3]

Status: Recruiting

BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe

BOREALIS is a multicentre, prospective, observational cohort study designed to investigate the effectiveness, feasibility, safety and impact on pain and quality of life of curative-intent cryoablation for the treatment of bone metastases in patients with oligometastatic or bone oligo-progressive disease.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cardiovascular and Interventional Radiological Society of EuropeUpdated: Dec 30, 2025Locations: 5Duration: 1 Year
Eligibility criteria

Bone metastases in patients with oligometastatic disease (<5 bone/visceral metas... [+5]

< 18 years old; [+9]